The results from MTT showed that activation of AR made MCF-7 (Figure 2e) and ZR-75 (Figure 2f) tolerant to tamoxifen, suggesting that activation of AR signaling can confer tamoxifen resistance in breast cancer. This evidence concerns the gene AR and breast carcinoma.